GreenLight Biosciences Holdings, PBC, listed under the ticker ENVI, is the post-de-SPAC entity formed through the business combination of Environmental Impact Acquisition Corp. — a blank-check company that completed its initial public offering in 2021 — and GreenLight Biosciences, Inc., an RNA-based biotechnology firm developing products for crop protection and human health. The company operates in the life sciences and agricultural biotechnology sectors. A Form 8-K was filed on May 30, 2023, under accession number 0001193125-23-155988, reflecting continued public reporting obligations following the completion of the merger. Sign up for full data on SpacDesk to access comprehensive filing histories, sponsor profiles, and deal analytics for ENVI and thousands of other SPAC transactions.